Hear from Assoc. Prof. Bas Vastert (Pediatric Rheumatologist and Immunologist) and Prof. Eugen Feist (Adult Rheumatologist and Immunologist) as they discuss Still’s disease and highlight the key updates from the 2024 EULAR/PreS recommendations.
Below you will find a few short clips from the full podcast to highlight some areas from the new Still's recommendations
How have the new EULAR-PreS recommendations changed the approach to diagnosing and managing Still's disease
What are the typical clinical manifestations observed in patients with Still’s disease
Does a ‘window of opportunity’ exist in the treatment of Still’s disease